Our latest podcast explores the innovative approach of neoadjuvant immunotherapy – administering checkpoint inhibitor immunotherapy before the surgical removal of melanoma. This promising approach...

PRAME is a tumour-associated antigen identified by autologous T-cell epitope in a patient with metastatic cutaneous melanoma. In this presentation Pathologist Dr Robert Rawson...

Lentigo maligna – a subtype of in situ melanoma – presents diagnostic and treatment challenges for clinicians. In this podcast, Dr Michael Rtshiladze leads...

The role of the Pathologist is crucial in the emerging field of neoadjuvant therapy in melanoma. Understanding that their role is fundamental to patient...

Despite recent advances in management of primary uveal melanoma, more than half of patients develop metastatic disease – often with poor outcomes. New therapeutic...

In this presentation, Pathologist Prof Richard Scolyer AO discusses how neoadjuvant therapy is transforming melanoma patient care. He also answers key questions around neoadjuvant-treated...

This presentation was recorded at A/Prof Alexander van Akkooi’s inaugural Australian lecture where he discusses his vision and aims for the future of melanoma...

The role of pathologist in the diagnosis and treatment of melanoma is pivotal to optimal patient care. With so many disciplines relying on the...

Cancer drugs have rapidly evolved in the last decade. Alongside the significant benefits are new toxicity profiles that clinicians need to be aware of...